𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic factors in well-differentiated early-stage epithelial ovarian cancer

✍ Scribed by J. A. Schueler; C. J. Cornelisse; J. Hermans; J. B. Trimbos; M. E. L. Van Der Burg; G. J. Fleuren


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
816 KB
Volume
71
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Prognostic factors for high-risk early-s
✍ John K. Chan; Chunqiao Tian; Bradley J. Monk; Thomas Herzog; Daniel S. Kapp; Jef πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 141 KB

## Abstract ## BACKGROUND. The purpose was to identify the factors predictive of recurrence and survival in patients with high‐risk (stage I, grade 3; stage IC, stage II, or clear cell) epithelial ovarian cancer after adjuvant therapy. ## METHODS. Data was extracted from patients who underwent p

Plasminogen activator inhibitor-1 is an
✍ Setsuko K. Chambers; Christina M. Ivins; Maria L. Carcangiu πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 103 KB πŸ‘ 2 views

High levels of plasminogen activator inhibitor-1 (PAI-1) in tissue extracts have been associated with poor prognosis in many epithelial cancers. Ovarian cancers contain a higher concentration of PAI-1 than benign ovarian tumors or normal ovaries. Reports, however, on the prognostic value of PAI-1 co

CD44 is an independent prognostic factor
✍ Paul Speiser; Christian Wanner; Clemens Tempfer; Maria MittelbΓΆck; Engelbert Han πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 58 KB πŸ‘ 2 views

The expression of specific cell-adhesion molecule CD44 isoforms (splice variants) is associated with metastatic spread and poor prognosis in human malignancies. The aim of this study was to evaluate whether CD44 isoform expression is a prognostic factor in early-stage cervical cancer. We used 4 diff